Physician profile
Michael S Firstenberg
NPI 1912961749
$46,007.25
in general payments reported to CMS, 2019-2025
25 companies · $2,813 in 2025
The $2,813 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $26K · 2020: $7,488 · 2021: $5,174 · 2022: $340 · 2023: $2,423 · 2024: $2,107 · 2025: $2,813.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,386 · Travel and Lodging: $581 · Consulting Fee: $375.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,385.78 |
| Travel and Lodging | $581.11 |
| Consulting Fee | $375.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $31,739.49 | 2019-2020 | |
| Abiomed | $5,501.10 | 2019-2025 | Impella |
| Baxter Healthcare | $3,231.59 | 2021 | |
| Medtronic, INC. | $2,283.72 | 2021-2025 | Avalus, Penditure, Surgidac |
| Spacelabs Healthcare INC | $1,623.81 | 2021 | |
| Bolton Medical INC | $246.92 | 2025 | Thoraflex Hybrid, Relay Thoracic Stent-Graft With Plus Delivery System |
| Artivion, INC. | $186.53 | 2019 | |
| Boston Scientific Corporation | $176.57 | 2020-2025 | General - Pain Management, Clik X |
| Portola Pharmaceuticals, LLC | $140.57 | 2020 | |
| Intuitive Surgical, INC. | $117.23 | 2025 | |
| Livanova USA, INC. | $106.66 | 2022 | |
| Tela Bio, INC. | $101.63 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Getinge USA Sales, LLC | $87.41 | 2023 | Fusion Bioline Supported Vascular Grafts |
| Edwards Lifesciences Corporation | $80.58 | 2021 | |
| Lsi Solutions INC | $77.21 | 2025 | Cor-Knot |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lemaitre Vascular, INC. | $73.08 | 2019 | |
| Sumitomo Pharma America, INC. | $63.19 | 2024 | Myfembree |
| Zimmer Biomet Holdings, INC. | $35.46 | 2021 | |
| Covidien Lp | $27.77 | 2019 | |
| Abbott Laboratories | $21.75 | 2020 | |
| Kls-Martin L.P. | $20.91 | 2019 | |
| Kci USA, INC. | $19.48 | 2019 | |
| Philips North America LLC | $15.74 | 2023 | |
| Biotronik INC. | $15.22 | 2019 | |
| Amgen INC. | $13.63 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Firstenberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.